Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

Giulio Metro, Alessandra Fabi, Maria A. Mirri, Antonello Vidiri, Andrea Pace, Mariantonia Carosi, Michelangelo Russillo, Marta Maschio, Diana Giannarelli, Domenica Pellegrini, Alfredo Pompili, Francesco Cognetti, Carmine M. Carapella

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences